why choose us

Clinical Trials Search

Showing 17,750 of 132,963 result(s)
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Status: COMPLETED

Condition: Healthy Participants

Interventions: Oral tablets

Date: 2022-12-01

Tau PET Imaging in Opioid Use Disorder

Status: COMPLETED

Condition: Opioid-Related Disorders

Interventions: DRUG: 18F-PI-2620 PET/CT - PET/CT imaging will be used to evaluate the uptake of tau in the brain using the investigational radiotracer \[18F\]PI-2620

Date: 2022-12-01

Physiology Optimized Versus Angio-guided PCI

Status: COMPLETED

Condition: Coronary Artery Disease

Interventions: FFR pullback trace is obtained through the manual retrieval performed after the positioning of the microcatheter FFR in the distal portion of the vess

Date: 2022-12-01

Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases

Status: Completed

Condition: Abdominal Hysterectomy

Interventions: Anesthesia induction was provided with propofol (2mg;kg), fentanyl (2mcg;kg).
Intubation was performed after administration of 0.6 mg&#

Date: 2022-12-01

Retinal Microvasculature by Optical Coherence Tomography Angiography During Integrating Physical Activity in Diabetic Subjects.

Status: Completed

Condition: Diabetes Complications

Interventions: Optical Coherence Tomography Angiography

Date: 2022-12-01

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

Status: NOT_YET_RECRUITING

Condition: Mild Cognitive Impairment

Interventions: A 6-month partially supervised walking exercise program using a tapered approach.Participants will begin exercise (walking) at a relatively low intens

Date: 2022-12-01

Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)

Status: Completed

Condition: Generalized Myasthenia Gravis

Interventions: Ravulizumab will be administered by intravenous (IV) infusion.

Date: 2022-12-01

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

Status: Completed

Condition: ABPA

Interventions: Capsules with 20 mg total powder (10 mg itraconazole plus 10 mg excipients)

Date: 2022-12-01

Tau PET Imaging in Opioid Use Disorder

Status: Completed

Condition: Opioid-Related Disorders

Interventions: PET;CT imaging will be used to evaluate the uptake of tau in the brain using the investigational radiotracer [18F]PI-2620.
Each subject will

Date: 2022-12-01

Bladder Cancer Screening Trial

Status: Completed

Condition: Bladder Cancer

Interventions:

Urine analysis (every 6 months for 2 years); Patients with <3 red blood cells (RBCs) per high-powered field (HPF) will repeat screening at 6-mon

Date: 2022-12-01